THE MOST IMPACTFUL CEO TO WATCH IN 2023
Dr Eric Leire
Founder & CEO, Genflow Biosciences
Empowering the World
In the rapidly advancing field of biotechnology, numerous individuals have made significant contributions and left a lasting impact on the industry. These leaders have forever revolutionized how we think about and utilize biological systems. These leaders possess a unique blend of scientific expertise, entrepreneurial spirit, and visionary thinking, which allowed them to shift paradigms and create new therapies for diseases, to developing cutting-edge tools and technologies that enable breakthroughs in genetic engineering and synthetic biology. These leaders are playing critical roles in shaping our future. Dr. Eric Leire, the CEO of Genflow Biosciences, is one such leader. He dedicates himself to the development of novel gene-based therapeutics targeting the aging process in dogs and humans.
An acute moral obligation drives Dr. Leire to develop safe, cost effective and ethical gene therapies to combat aging. By focusing on improving our ‘healthspan’ – the time we spend in good health – Dr. Leire’sGenflow Biosciences
therapies impact the biological drivers of aging rather than simply treating age-related diseases such as type 2 diabetes, cardiovascular diseases, neurodegenerative diseases or cancers.
“I have a profound passion for the mission of our company, the work we do, and the team I lead”, shares – Dr. Leire. “Our company’s mission statement and values are deeply ingrained in me, and I aspire to instill the same level of passion in others. It’s a privilege to work with such a remarkable team of individuals who are committed to science and its potential impact on society and people’s lives”, he continued. Being able to work on something that holds such significance and promise for countless individuals is truly gratifying for Dr. Leire, and he cherishes this opportunity every day.
Creating a Healthier World
As the Genflow CEO, Dr. Eric Leire is always with his team, working collaboratively to achieve common goals. The organization places a high value on their shared values and psychological safety, which enable Dr. Leire to provide and earn constant feedback which encourage innovation. The team achieves the highest standard of scientific excellence, which is their ultimate objective. Under Dr. Leire’s leadership, Genflow and its partners recognize and appreciate the team’s diversity and actively seek to leverage unique differences through co-creation and pushing boundaries.
When asked about his greatest achievement, Dr. Leire shared – “Securing the financing of our scientific development for the next 2 years through our IPO on London Stock Exchange (GENF.L) and building an exceptional team of researchers who contribute to better understand the processes of aging, because the simple truth is: we all age; but we do not all age equally. Aging can now be considered as a risk factor that we can manage. By treating aging, we believe that Genflow Biosciences cancontribute to decrease healthcare costs and lessen the emotional, financial and societal burden that comes with an aging population.”
Short term, Dr. Leire and his team’s primary objective is to execute the scientific pre-clinical programs that will allow the company to initiate clinical trials in Humans, engage with health regulatory authorities such as EMA, FDA, and MHRA, and expand the pipeline of anti-aging therapy candidates. Additionally, Genflow is focused on establishing itself as one of the top 10 pure play longevity research biotech companies. In the long term, the goal is to be acquired by a pharmaceutical partner who can leverage their expertise to commercialize their therapies to a wider audience.
Looking Ahead
Going down the lane Ms. Schuster aims to address the challenges posed by climate change through their parking spaces by providing not only parking solutions, but also charging and refueling options for vehicles using alternative fuels such as bio-LNG and hydrogen at their car parks. Already knowing the fact that this endeavor requires significant investments, which Park Your Truck is currently pursuing investors for, the Company looks forward towards utilization of clean electricity
as independent of the grid as possible.
In other news, Park Your Truck has already implemented solar roofs to cover their areas, and hired new employees with expertise in the energy market to further develop their car parks. In the upcoming year, Park Your Truck plans to electrify 200 sites for last-mile transport and 13 sites per year for 40-tonne trucks across Europe. Lastly, the Company is also expanding their reservation system to make the charging stations reservable for their customers, and Ms. Schuster herself is extremely pumped talking about the various developments that will enable the company to play a part in promoting sustainable transportation practices.
Beyond Genflow
His family Dr. Leire’s whole world. He knows that his wife and children will always provide him with unwavering support and guidance, no matter what. He has a supportive group of friends who, like him, prioritize living a life that aligns with their values. Dr. Leire takes his health seriously and recognizes the importance of maintaining strong relationships as a critical component of overall well-being. He manages his lifestyle by following the ‘healthspan’ science he not only researches but lives every day.
Thankfully, his parents were committed to offering the best education possible to their five kids, through which Dr. Leire benefitted from the ethos that learning and seeking knowledge are some of the most critical pursuits in life. He inspires his own children to find joy and meaning in education and to share those ideals with the wider community as a civic responsibility.
ALSO IN THIS EDITION
RELATED INSIGHTS
LEADERSHIP
INNOVATION
STRATEGY
FINANCE
GLOBAL BUSINESS
CULTURE & PEOPLE
LEADERSHIP
More featured leaders
THE VICTORY MAGAZINE APPLICATIONS OPEN
Your story belongs on a global stage.